Machine learning to successfully predict the risk of developing possibly life-threatening infection from the genomic features of a bacterial isolate.
New research shows that an experimental HIV vaccine strategy works in non-human primates. In the study, rhesus macaque monkeys produced neutralizing antibodies against one strain of HIV that resembles the resilient viral form that most commonly infects people, called a Tier 2 virus.
In Mozambique, the probability of dying in the first month after hospital discharge is high, particularly for babies under three months of age, shows a study led by ISGlobal. The study also shows that an algorithm based on simple clinical parameters can identify those children at higher risk of dying and that would therefore benefit from follow-up after discharge. Implementation of these models could contribute to reducing child mortality in low-income countries.
Face masks appear to provide important protection against drug-resistant Staphylococcus aureus bacteria for hog farm workers and for household members to whom they might otherwise transmit the bacteria, according to a study led by scientists at Johns Hopkins Bloomberg School of Public Health.
A new study shows that fecal bacteria from sewage are living in far greater quantities in near-shore sediments of the Hudson River than in the water itself. The river's pollution levels are generally monitored based on samples of clear water, not sediments, so the findings suggest that people stirring up the bottom while wading, swimming or kayaking may face previously unrecognized health risks.
Home healthcare workers' beliefs about infection prevention influence whether they comply with prevention protocols more than their actual knowledge of how to comply, according to new research published in the American Journal of Infection Control (AJIC), the journal of the Association for Professionals in Infection Control and Epidemiology (APIC).
A protein family found naturally in our cells could help stop the spread of dangerous drug resistant infections by using 'detective' like powers to collect evidence of bacterial infection and imprison it, according to new research published in the journal Cell Host & Microbe.
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. Scientists from the Gladstone Institutes and UC San Francisco may finally change that. They identified key ways the three viruses hijack the body's cells, and they found at least one potential drug that can disrupt this process in human cells.
Johns Hopkins researchers have observed a previously unrecognized behavior in a single-celled parasite called Spironucleus vortens, which infects ornamental fish such as angelfish: The protozoans swarm.
Researchers have discovered a human protein that helps fight the Ebola virus and could one day lead to an effective therapy against the deadly disease, according to a new Northwestern Medicine study. The newly discovered ability of the human protein RBBP6 to interfere with Ebola virus replication suggests new ways to fight the infection. 'What we envision is a small molecule drug that mimics this human protein and could be used in response to an Ebola virus outbreak.'